The Cure We Chose Not to Build: Nanobots, the Business of Dying, and the Singularity's Broken Promise
Ray Kurzweil predicts nanobots in our bloodstream by the 2030s and escape velocity in longevity by 2032. The technology to conquer disease and perhaps death itself is on the horizon. So why is 80% of global venture capital flowing into AI weapons and space colonization while hospitals allocate just 4.2% of their IT budgets to AI? A philosophical examination of the VUCA world, the business of dying, and the singularity's broken promise.

